Vijaya Diagnostic CEN Ltd
NSE: VIJAYA · Healthcare Service Provider · sector
₹1,395.80NSE close 2026-10-26
Key numbers
Market cap₹14,362 cr
Price₹1,395.80
52w high / low₹1,594 / ₹848
P/E76.6xSector median 22.9x
P/B15.0xSector median 2.0x
Book value₹93.0
Dividend yield0.14%Sector median 0.55%
ROE21.4%Sector median 5.4%
ROCE30.1%Sector median 6.8%
OPM42.2%Sector median 15.9%
Debt / equity0.00xSector median 0.07x
EV/EBITDA38.9xSector median 17.2x
Interest cover7.8x
Current ratio2.60x
Sales growth 3y+21.0%Sector median +13.5%
Profit growth 3y+26.9%Sector median +26.9%
PEG2.88x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹281 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 7.8x in the last 12 months.
- 1.96% of the promoters' shares are pledged (1.0% of all shares).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 12% of net profit in the last 12 months.
- Dividend paid in 4 of the last 5 financial years.
- Price ₹1,395.80 on 2026-10-26: -12.4% from the 52-week high, +64.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,526.50 · low ₹883.20
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 | 205 | 219 | 231 |
| EBITDA | 76 | 67 | 68 | 74 | 82 | 86 | 96 | 99 |
| OPM % | 41.5% | 39.7% | 39.2% | 39.1% | 40.6% | 41.9% | 43.5% | 42.7% |
| Other income | 5 | 5 | 6 | 7 | 6 | 5 | 2 | 9 |
| Net profit | 42 | 35 | 35 | 38 | 43 | 43 | 48 | 53 |
| EPS (₹) | 4.09 | 3.42 | 3.38 | 3.76 | 4.21 | 4.20 | 4.66 | 5.16 |
| Revenue YoY | +10.2% | +21.4% | +26.6% | +22.8% | ||||
| Profit YoY | +3.2% | +22.8% | +38.4% | +38.5% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 462 | 459 | 548 | 681 | 814 | 857 |
| EBITDA | 204 | 182 | 219 | 272 | 337 | 362 |
| Net profit | 110 | 85 | 119 | 143 | 173 | 187 |
| EPS (₹) | 10.76 | 8.29 | 11.62 | 13.95 | 16.81 | 18.23 |
| Revenue growth | -0.7% | +19.3% | +24.4% | +19.5% | +20.2% | |
| Profit growth | -22.8% | +40.4% | +20.4% | +20.9% | +24.9% | |
| Dividend / share (₹) | – | 1.00 | 1.00 | 1.00 | 2.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +21.0% | – | +20.2% |
| Net profit | +26.9% | – | +24.9% |
| EPS | +26.6% | – | – |
| Share price | – | +18.2% (2y) | +35.4% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 545 | 657 | 796 | 957 |
| Borrowings | – | 0 | 0 | 0 | 0 |
| Cash & equivalents | – | 255 | 182 | 233 | 281 |
| Total assets | – | 853 | 983 | 1,274 | 1,507 |
| Fixed assets | – | 294 | 602 | 724 | 930 |
| Capital work in progress | – | 249 | 8 | 70 | 34 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 9 | 16 | 15 | 21 |
| Inventory | – | 2 | 5 | 5 | 5 |
| Payables | – | 28 | 33 | 33 | 38 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 158 | 165 | 183 | 224 | 271 |
| Cash from investing | -123 | -110 | -142 | -182 | -174 |
| Cash from financing | -31 | -42 | -45 | -52 | -69 |
| Capex | 122 | 125 | 88 | 96 | 183 |
| Free cash flow | 36 | 40 | 95 | 129 | 88 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 15.5% | 18.1% | 18.0% | 18.1% |
| ROCE % | – | 24.7% | 27.8% | 27.6% | 27.8% |
| Debtor days | – | 8 | 11 | 8 | 9 |
| Inventory days | – | 13 | 29 | 21 | 19 |
| Payable days | – | 172 | 184 | 143 | 145 |
| Cash conversion cycle (days) | – | -151 | -144 | -114 | -117 |
| Working capital days | – | 167 | 92 | 77 | 89 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 52.46% |
| FIIs | 10.66% |
| DIIs | 32.50% |
| of which Mutual funds | 31.44% |
| of which Insurance | 0.53% |
| Government | 0.00% |
| Public (non-institutions) | 4.38% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 53.91% | 53.05% | 52.63% | 52.60% | 52.60% | 52.51% | 52.51% | 52.46% |
| Promoter group | % |
|---|---|
| Surendranath Reddy Sura | 32.20% |
| Suprita Sura Reddy | 8.71% |
| Sunil Chandra Kondapally | 7.55% |
| Geetha Reddy Sura | 3.94% |
| Birudavolu Vishnu Priya | 0.03% |
| P Madhulika | 0.01% |
| Venkata Sanjay Kumar Puligoru | 0.01% |
| Birudavolu Dayakar Reddy | 0.00% |
| Birudavolu Gautam | 0.00% |
| Birudavolu Jalaja | 0.00% |
| Birudavolu Charitha Reddy | 0.00% |
| Nanda Kumar Birudavolu | 0.00% |
| Manjula Kankanti | 0.00% |
| Vijaya Holdings India LLP | 0.00% |
| Public holders above 1% | % |
|---|---|
| Kotak Mahindra Trustee Co Ltd A/C Kotak Business C | 6.59% |
| HDFC Mutual Fund - HDFC Childrens Fund | 5.57% |
| Nippon Life India Trustee Ltd-a/c Nippon India MUL | 4.53% |
| HSBC Mutual Fund - HSBC Aggressive Hybrid Fund | 3.43% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual F | 3.42% |
| ICICI Prudential Smallcap Index Fund | 2.56% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 1.29% |
| Verdipapirfondet Odin Emerging Markets | 1.02% |
70,966 shareholders. Pledged: 1.96% of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-16 | Dividend | Dividend - Rs 2 Per Share |
| 2025-08-29 | Dividend | Dividend - Rs 2 Per Share |
| 2024-08-30 | Dividend | Dividend - Re 1 Per Share |
| 2023-09-13 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 2022-09-20 | Dividend | Dividend - Re 1 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Other Human Health Activities: Activities of Independent Diagnostics/Pathological Laboratories
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | VIJAYA |
| BSE code | 543350 |
| ISIN | INE043W01024 |
| Face value | ₹1.0 |
| Incorporated | 2002-06-05 |
| Website | www.vijayadiagnostic.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.